Haemonetics Corporation
$101.95
-1.12 (-1.09%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +17.5%
- 3 Months
- +53.6%
- YTD
- +27.2%
- 1 Year
- +86.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 49.4%
- Largest decline max drawdown, since Aug 2025
- -40.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.49
Own HAE?
See how HAE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.